title: First drug is approved under scheme that gives patients access to unlicensed medicines.
authors.affiliation: London.
authors.forename: Nigel
authors.initials: N
authors.lastname: Hawkes
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D017277:Drug Approval; D006297:Health Services Accessibility / Q000458:organization & administration*; D006801:Humans; D008545:Melanoma / Q000188:drug therapy; D006113:United Kingdom
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C582435:pembrolizumab